In most recent advancements, RNA editing uses the CRISPR-Cas13 system, a newer technique that was created specifically to help develop therapies that work with RNA. DNA editing is permanent, which ...

ProQR ( ) just unveiled an announcement. ProQR Therapeutics announced significant advancements in their Axiomer RNA-editing platform during their 2024 Investor and Analyst Event.

Mammalian RNAs can be edited by the conversion of adenosine to inosine, which is read as guanosine, but technological constraints have limited our view of the overall contribution of RNA editing ...

Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering new RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD). Wave claims this is the first clinical ...

The only industry-led meeting showcasing the recent development of RNA editing mechanisms and dedicated to realizing the research and therapeutics opportunity of RNA editing as quickly as possible.

ProQR (PRQR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Jonathan Wolleben from JMP ...

The researchers for the first time used an RNA editing tool—known as CRISPR Cas13—to suppress the production of Vascular ...

New research has identified a critical fall-back mechanism used by the cells when the usual RNA editing process is switched off. Professor Carl Walkley heads the RNA Biology and Innate Immune ...

Exciting potential in Korro Bio, Inc.'s non-viral gene editing platform as they enter clinical trials with a strong cash ...

By studying this amazing structure, how did scientists learn about RNA editing? The first tools developed for the study of cells and tissues were optical microscopes. These microscopes use visible ...

ProQR Therapeutics announced significant advancements in their Axiomer RNA-editing platform during their 2024 Investor and Analyst Event. The company highlighted the platform’s potential to ...